Uncontrolled Phase II Cancer studies

• uncontrolled series in advanced bowel cancer

• 20 different cases series of rapid injection 5-FU

• among 6 largest (n= 40 to 150)

  • response rates ranged from 11% to 55%

Previous slide

Next slide

Back to first slide

View graphic version